Jonathan Kimmelman

Blogging today’s FDA stem cell meeting: Part 2 Clinics, Policy & Ethics

Jonathan-Kimmelman-FDA-e1473490111453

The FDA is holding its first 2016 stem cell meeting today and you can read about some impressions of the morning session of this meeting here. In this post, I’m focusing on the afternoon session, which has been mostly on policy and ethics, including on stem cell clinics. Jonathan Kimmelman from McGill University got the afternoon going …

Blogging today’s FDA stem cell meeting: Part 2 Clinics, Policy & Ethics Read More »

Wait, there’s an FDA stem cell meeting this week too? The scoop

stem-cell-crystal-ball

There’s a big FDA stem cell meeting coming along next week that has gotten much attention, but many people didn’t realize there’s also an FDA meeting on stem cells this week too in three days on September 8th. I pasted this week’s meeting schedule at the bottom of this post from the FDA page. The meeting is …

Wait, there’s an FDA stem cell meeting this week too? The scoop Read More »

Huge clinical trial patient fees allowed by FDA at times, details often secret

Monopoly1-300x2851

I am often critical of for-profit stem cell clinics on this blog for numerous reasons. For instance, one thing that concerns me greatly about these clinics is that they charge patients to get experimental “treatments” that have not been proven to be safe or effective. But as some patients have pointed out to me over the …

Huge clinical trial patient fees allowed by FDA at times, details often secret Read More »

ISSCR Releases Flood of Stem Cell Policy Docs

ISSCR-Policy-Guidelines-2016

A committee of the International Society for Stem Cell Research (ISSCR) did one heck of a document dump yesterday on stem cell policy, releasing a whole bunch of policy recommendations on stem cells and more. The torrent from ISSCR included a 37-page policy statement itself as well as several papers in top journals including the …

ISSCR Releases Flood of Stem Cell Policy Docs Read More »

Live Blogging #GeneEditSummit Day 2 Post #1: Governance of human gene editing

Barbara-J.-Evans

Now we have an interesting panel starting on questions of governance on human gene editing. This will focus on institutional and national levels of governance. Pilar N. Ossorio, University of Wisconsin, Madison, and Morgridge Institute for Research, is introducing the panel. Key question: how should emerging technologies being governed? Jonathan Kimmelman, from McGill, was the first …

Live Blogging #GeneEditSummit Day 2 Post #1: Governance of human gene editing Read More »